Study of HX008 for the Treatment of Anaplastic Thyroid Cancer (ATC)
NCT04574817
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
66
Enrollment
INDUSTRY
Sponsor class
Conditions
Anaplastic Thyroid Cancer
Interventions
DRUG:
HX008
Sponsor
Taizhou Hanzhong biomedical co. LTD